Drug-DNA recognition: Energetics and implications for design

Journal of Molecular Recognition

Volumn 13, Issue 4, 2000, Pages 188-197

  Ihtshamul, Haq ^a   Ladbury, John ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Calorimetry; DNA drug interactions; Drug design; Energetics; Molecular recognition; Tetraplex DNA; Thermodynamics; Triplex DNA

Indexed keywords

BINDING KINETICS; DESIGN OPTIMIZATION; DOUBLE STRANDED DNA; DRUG DESIGN; DRUG DNA INTERACTION; THERMODYNAMICS;

BINDING SITES; CALORIMETRY; CRYSTALLOGRAPHY, X-RAY; DNA; DRUG DESIGN; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; PHARMACEUTICAL PREPARATIONS; THERMODYNAMICS;

EID: 0343167423     PISSN: 09523499     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-1352(200007/08)13:4<188::AID-JMR503>3.0.CO;2-1     Document Type: Review

References (83)

1. Agbandje M, Jenkins TC, McKenna R, Reszka AP, Niedle S. 1992. Anthracene-9,10-diones as potential anticancer agents -synthesis, DNA-binding and biological studies on a series of 2,6-disubstituted derivatives. J. Med. Chem. 35: 1418-1429.
2. 4. Biochemistry, 37: 2709-2714.
3. Arthanari H, Basu S, Kawano TL, Bolton PH. 1998. Fluorescent dyes specific for quadraplex DNA. Nucleic Acids Res. 26: 3724-3728.
4. Blackburn EH. 1991. Structure and function of telomeres. Nature, 350: 569-573.
5. Bostock-Smith CE, Gimenez-Arnau E, Missailidis S, Laughton CA, Stevens MFG, Searle MS. 1999. Molecular recognition between a new pentacyclic acridinium salt and DNA sequences investigated by optical spectroscopic techniques, proton NMR spectroscopy and molecular modelling. Biochemistry 38: 6723-6731.
6. Chaires JB. 1996. Dissecting the free energy of drug binding to DNA. Anti Cancer Drug Des. 11: 569-580.
7. Chaires JB. 1998a. Energetics of DNA drug interactions. Biopolymers 44: 201-215.
8. Chaires JB. 1998b. Drug-DNA interactions. Curr. Opin. Struct. Biol. 8: 314-320.
9. Chaires JB, Leng F, Przewloka T, Fokt I, Ling YH, Perez-Soler R, Priebe W. 1997. Structure-based design of a new bisintercalating anthracycline antibiotic. J. Med. Chem. 40: 261-266.
10. Chen X, Ramakrishnan B, Rao ST, Sundaralingam M. 1994. Binding of two distamycin molecules in the minor-groove of an alternating B-DNA duplex. Nat. Struct. Biol. 1: 169-175.
11. Chen Q, Kuntz ID, Shafer RH. 1996. Spectroscopic recognition of guanine dimeric hairpin quadraplexes by a carbocyanine dye. Proc. Natl Acad. Sci. USA, 93: 2635-2639.
12. Denny WA, Wakelin LPG. 1990. Kinetics of the binding of mitoxantrone, ametantrone and analogs to DNA - relationships with binding mode and antitumour activity. Anti Cancer Drug Des. 5: 189-200.
13. Dervan PB, Bürli RW. 1999. Sequence-specific DNA recognition by polyamides. Curr. Opin. Chem. Biol. 3: 688-693.
14. Dickerson LA, Gulizia RJ, Trauger JW, Baird EE, Mosier DE, Gottersfeld JM, Dervan PB. 1998. Inhibition of RNA polymerase II transcription in human cells by synthetic DNA binding ligands. Proc. Natl Acad. Sci. USA, 95: 12890-12895.
15. Dutta R, Gao Y-G, Priebe W, Wang H-J. 1998. Binding of the modified daunorubicin WP401 adjacent to a T-G base pair induces the reverse Watson-Crick conformation: crystal structures of the WP401-TGGCCG and WP401-CGG[BR5C]CG complexes. Nucleic Acids Res. 26: 3001-3005.
16. Escudé C, Nguyen CH, Mergny JL, Sun JS, Bisagni E, Garestier T, Hélène C. 1995. Selective stabilisation of DNA triple helices by benzopyridoindole derivatives. J. Am. Chem. Soc. 117: 10212-10219.
17. Escudé C, Nguyen CH, Kukreti S, Janin Y, Sun JS, Bisagni E, Garestier T, Hélène C. 1998. Rational design of a triple helix-specific intercalating ligand. Proc. Natl Acad. Sci. USA 95: 3591-3596.
18. Fedoroff OY, Salazar M, Han H, Chemeris VV, Kerwin SM, Hurley LH. 1998. NMR-based model of a telomerase-inhibiting compound bound to G-quadraplex DNA. Biochemistry 37: 12367-12374.
19. Fox KR. 2000. Targeting DNA with triplexes. Curr. Med. Chem. 7: 17-37.
20. Fox KR, Polucci P, Jenkin TC, Niedle S. 1995. A molecular anchor for stabilizing triple-helical DNA. Proc. Natl Acad. Sci. USA 92: 7887-7891.
21. Fox KR, Thurston DE, Jenkins TC, Varvaresou A, Tsotinis A, Siatra-Papastaikoudi T. 1996. A novel series of DNA triple-helix binding ligands. Biochem. Biophys. Res. Commun. 224: 717-720.
22. Geierstanger BH, Dwyer TJ, Bathini Y, Lown JW, Wemmer DE. 1993. NMR characterization of a heterocomplex formed by distamycin and its analog 2-IMD with d(CGCAAGTTGGC)-d(GCCAACTTGCG) - preferences for the 1:1:1 2-IMD-DST-DNA complex over the 2:1 2-IMD-DNA and the 2:1 DST-DNA complexes. J. Am. Chem. Soc. 115: 4474-4482.
23. Geierstanger BH, Mrksich M, Dervan PB, Wemmer DE. 1994. Design of a G-C specific DNA minor groove binding peptide. Science 266: 646-650.
24. Gilbert DE, Feigon J. 1999. Multistranded DNA structures. Curr. Opin. Struct. Biol. 9: 305-314.
25. Gottersfeld JM, Neely L, Trauger JW, Baird EE, Dervan PB. 1997. Regulation of gene expression by small molecules. Nature 387: 202-205.
26. Greider CW, Blackburn EH. 1985. Identification of specific telomere terminal transferase activity in Tetrehymena extracts. Cell 43: 405-413.
27. Guo Q, Lu M, Marky LA, Kallenbach NR. 1992. Intercalation of the dye ethidium bromide with DNA containing guanine repeats. Biochemistry 31: 2451-2455.
28. Haq I. 1998. Isothermal titration calorimetry in the study of DNA-drug interactions. In Biocalorimetry: Applications of Calorimetry in the Biological Sciences. (Chowdhry BZ, Ladbury JE. Eds). Wiley, Chichester.
29. Haq I, Ladbury JE, Chowdhry BZ, Jenkins TC. 1996. Molecular anchoring of duplex and triplex DNA by disubstituted anthracene-9,10-diones: calorimetric, UV melting and competition dialysis studies. J. Am. Chem. Soc. 118: 10693-10701.
30. 2 duplex: calorimetric and spectroscopic studies. J. Mol. Biol. 271: 244-257.
31. Haq I, Trent JO, Chowdhry BZ, Jenkins TC. 1999. Intercalative G-tetraplex stabilization of telomeric DNA by a cationic porphyrin. J. Am. Chem. Soc. 121: 1768-1779.
32. Haq I, Jenkins TC, Chowdhry BZ, Ren J, Chaires JB. 2000. Parsing the free energy of drug-DNA interactions. Meth. Enzymol. 323: 373-405.
33. Hu GG, Shui X, Leng F, Priebe W, Chaires JB, Williams LD. 1997. Structure of a DNA-bisdaunomycin complex. Biochemistry 36: 5940-5946.
34. Hurley LH, Boyd FL. 1988. DNA as a target for drug action. Trends Pharm. Sci. 9: 402-407.
35. Izbicka E, Wheelhouse RT, Raymond E, Davidson KK, Lawrence RA, Sun D, Windle BE, Hurley LH, Von Hoff DD. 1999. Effects of cationic porphyrins as G-quadraplex interactive agents in human tumour cells. Cancer Res. 59: 639-644.
36. Jelesarov I, Bosshard HR. 1999. Isothermal titration calorimetry and differential scanning calorimetry as complementary tools to investigate the energetics of biomolecular recognition. J. Mol. Recogn. 12: 3-18.
37. Jenkins TC. 2000. Targeting multi-stranded DNA structures. Curr. Med. Chem. 7: 99-115.
38. 3T). Proc. Natl Acad. Sci. USA, 89: 8832-8836.
39. Kang C, Zhang X, Ratliff R, Moyzis R, Rich A. 1992. Crystal structure of four-stranded Oxytricha telomeric DNA. Nature 356: 126-131.
40. Kielkopf CL, White SE, Szewczyk JW, Turner JM, Baird EE, Dervan PB, Rees DC. 1998a. A structural basis for recognition of AT and T-A base pairs in the minor groove of B-DNA. Science 282: 111-115.
41. Kielkopf CL, Baird EE, Dervan PB, Rees DC. 1998b. Structural basis for G-C recognition in the DNA minor groove. Nat. Struct. Biol. 5: 104-109.
42. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL, Shay JW. 1994. Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015.
43. Kim SK, Sun JS, Garestier T, Hélène C, Nguyen CH, Bisagni E, Rodger A, Norden B. 1997. Binding geometries of triple helix selective of benzopyrido[4,3-b]indole ligands complexed with double- and triple-helical polynucleotides. Biopolymers 42: 101-111.
44. 2. J. Mol. Biol. 183: 553-563.
45. Kopka ML, Yoon C, Goodsell D, Pjura P, Dickerson RE. 1985b. The molecular origin of DNA drug specificity in netropsin and distamycin. Proc. Natl Acad. Sci. USA 82: 1376-1380.
46. Ladbury JE. 1995. Counting the calories to stay in the groove. Structure 3: 635-639.
47. Laughlan G, Murchie AIH, Norman DG, Moore MH, Moody PCE, Lilley DMJ, Luisi B. 1994. The high resolution crystal structure of a parallel stranded guanine tetraplex. Science 265: 520-524.
48. Leng F, Priebe W, Chaires JB. 1998. Ultralight DNA binding of a new bisintercalating anthracycline antibiotic. Biochemistry 37: 1743-1753.
49. Lerman LS. 1961. Structural considerations in the interaction of DNA and acridines. J. Mol. Biol. 3: 18-30.
50. Lerman LS. 1963. The structure of the DNA-acridine complex. Proc. Natl Acad. Sci. USA 49: 94-102.
51. Lown JW, Krowicki K, Bhat UG, Skorobogaty A, Ward B, Dabrowiak JC. 1986. Molecular recognition between oligo-peptides and nucleic acids: novel imidazole containing oligopeptides related to netropsin that exhibit altered DNA sequence specificity. Biochemistry 25: 7408-7416.
52. Makarov VL, Hirose Y, Langmore JP. 1997. Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening. Cell 88: 657-666.
53. Marky LA, Alessi K, Rentzeperis D. 1996. Calorimetric studies of drug-DNA interactions. In Advances in DNA Sequence Specific Agents, Vol 2 (Hurley L. H. and Chaires J. B. Eds.) JAI Press, Greenwich, CT.
54. Mergny JL, Duval-Valentin G, Nguyen CH, Perrouault L, Faucon B, Rougée M, Montenay-Garestier T, Bisagni E, Hélène C. 1992. Triple helix-specific ligands. Science 256: 1681-1684.
55. Mergny J-L, Mailliet P, Lavelle F, Riou J-F, Laoui A, Hélène C. 1999. The development of telomerase inhibitors: the G-quartet approach. Anti Cancer Drug Des. 14: 327-339.
56. Mrksich M, Wade WS, Dwyer TJ, Geierstanger BH, Wemmer DE, Dervan PB. 1992. Antiparallel side-by-side dimeric motif for sequence-specific recognition in the minor groove of DNA by the designed peptide 1-methylimidazole-2-carboxamide netropsin. Proc. Nat. Acad. Sci. USA 89: 7586-7590.
57. Mrksich M, Parks ME, Dervan PB. 1994. Hairpin peptide motif: a new class of oligopeptides for sequence-specific recognition in the minor groove of double helical DNA. J. Am. Chem. Soc. 1165: 7983-7988.
58. Nguyen CH, Marchand C, Delage S, Sun JS, Garestier T, Hélène C, Bisagni E. 1998. Synthesis of 13H-benzo[6,7]- and 13H-benzo[4,5]indolo[3,2-c]-quinoline: a new series of potent specific ligands for triplex DNA. J. Am. Chem. Soc. 120: 2501-2507.
59. Niedle S, Jenkins TC. 1991. Molecular modelling to study DNA intercalation by antitumour drugs. Meth. Enzymol. 203: 433-458.
60. Perry PJ, Jenkins TC. 1999. Recent advances in the development of telomerase inhibitors for the treatment of cancer. Expert Opin. Invest. Drugs 8: 1981-2008.
61. Perry PJ, Kelland LR. 1998. Telomeres and telomerase: targets for cancer chemotherapy? Expert Opin. Ther. Patents 8: 1567-1586.
62. Perry PJ, Reszka AP, Wood AA, Read MA, Gowan SM, Dosanjh HS, Trent JO, Jenkins TC, Kelland LR, Niedle S. 1998a. Human telomerase inhibition by regioisomeric disubstituted amidoanthracene-9,10-diones. J. Med. Chem. 41: 4873-4884.
63. Perry PJ, Gowan SM, Reszka AP, Polucci P, Jenkins TC, Kelland LR, Niedle S. 1998b. 1,4- and 2,6-disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase. J. Med. Chem. 41: 3253-3260.
64. Pilch DS, Poklar N, Gelfand CA, Law SM, Breslauer KJ, Baird EE, Deravn PB. 1996. Binding of a hairpin polyamide in the minor groove of DNA: sequence-specific enthalpic discrimination. Proc. Natl Acad. Sci. USA 93: 8306-8311.
65. Pilch DS, Poklar N, Baird EE, Dervan PB, Breslauer KJ. 1999. The thermodynamics of polyamide-DNA recognition: hairpin polyamide binding in the minor groove of duplex DNA. Biochemistry 38: 2143-2151.
66. Plum GE. 1998. Thermodynamics of olgonucleotide triple helices. Bioploymers 44: 241-256.
67. Praseuth D, Guieysse AL, Hélène C. 1999. Triple helix formation and the antigene strategy for sequence-specific control of gene expression. Biochim. Biophys. Acta 1489: 181-206.
68. Priebe W. 1995. Anthracycline Antibiotics: New Analogues, Methods of Delivery and Mechanisms of Action. ACS Symposium Series 574, Americal Chemical Society, Washington, DC.
69. Ren J, Chaires JB. 2000. Preferential binding of 3,3-Diethyloxa-dicarbocyanine to triplex DNA. J. Am. Chem. Soc. 122: 424-425.
70. Robinson H, Priebe W, Chaires JB, Wang AH. 1997. Binding of two novel bisdaunorubicins to DNA studies by NMR spectroscopy. Biochemistry 36: 8663-8670.
71. Shafer RH. 1998. Stability and structure of model DNA triplexes and quadraplexes and their interactions with small ligands. Prog. Nuceic Acid Res. Mol. Biol. 59: 55-94.
72. Shida T, Ikeda N, Sekiguchi J. 1996. Drug binding to higher-order DNA structures: ethidium bromide complexation with parallel quadruple-stranded DNA. Nucleosides Nucleotides 15: 599-605.
73. Suh D, Chaires JB. 1995. Criteria for the mode of binding of DNA binding agents. Bioorg. Med. Chem. 3: 723-728.
74. Sun D, Thompson B, Gathers BE, Salazar M, Kerwin SM,Trent JO, Jenkins TC, Niedle S, Hurley LH. 1997. Inhibition of human telomerase by a G-quadraplex-interactive compound. J. Med. Chem. 40: 2113-2116.
75. Tanious FA, Jenkins TC, Niedle S, Wilson WD. 1992. Substituent position dictates the intercalative DNA-binding mode for anthracene-9,10-dione antitumour drugs. Biochemistry 31: 11632-11640.
76. Venitt S, Crofton-Sleigh C, Agbandje M, Jenkins TC, Niedls S. 1998. Anthracene-9,10-dionesas potential anticancer agents: bacterial mutation studies of amido-substituted derivatives reveals an unexpected lack of mutagenicity. J. Med. Chem. 41: 3748-3752.
77. Wade WS, Mrksich M, Dervan PB. 1992. Design of peptides that bind in the minor groove of DNA at 5′-(A,T)G(A,T)C(A,T)-3′ sequences by a dimeric side-by-side motif. J. Am. Chem. Soc. 114: 8783-8794.
78. 2 with quadraplex DNA. Structural basis for the differential effects on telomerase inhibition. J. Am. Chem. Soc. 121: 3561-3570.
79. White S, Baird EE, Dervan PB. 1997 On the pairing rules for recognition in the minor groove of DNA by pyrrole-imidazole polyamides. Chem. Biol. 4: 569-578.
80. White S, Szewczyk JW, Turner JM, Baird EE, Dervan PB. 1998. Recognition of four Watson-Crick base pairs in the minor groove by synthetic ligands. Nature 391: 468-471.
81. Williamson JR, Raghuraman MK, Cech TR. 1989. Monovalent cation-induced structure of telomeric DNA: the G-quartet model. Cell 59: 871-880.
82. Wilson WD, Tanious FA, Mizan S, Yao S, Kiselyov AS, Zon G, Strekowski LB. 1993. DNA triple-helix specific intercalators as antigene enhancers - unfused aromatic cations. Biochemistry 32: 10614-10621.
83. Zahler AM, Williamson JR, Cech TR, Prescott DM. 1991. Inhibition of telomerase by G-quartet DNA structures. Nature 350: 718-720.